Events Archives - Page 59 of 128

4 minute read

Assembly Biosciences Presents New Data Highlighting Entry Inhibitor And Core Inhibitor Programs At European Association For The Study Of The Liver International Liver Congress, On June 21-24, 2023

June 21, 8:16 AM

Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced data from its hepatitis D virus (HDV) and hepatitis B

ASMB

2 minute read

Cidara Therapeutics To Present Ongoing Development Of Drug-Fc Conjugates Including CD73-Targeting DFC From Its Cloudbreak Platform At Adenosine-Pathway Targeted Cancer Immunotherapy Summit Held June 20-22, 2023

By Happy Mohamed

June 20, 10:03 AM

Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today announced that the company

CDTX

2 minute read

MindMed Provides Overview Of Clinical Progress And Corporate Updates At Investor Day

By Happy Mohamed

June 20, 8:37 AM

Mind Medicine (MindMed) Inc (NASDAQ:MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health

MNMD

2 minute read

Timber Pharmaceuticals To Present Interim Analyses From Phase 3 ASCEND Study Of TMB-001 In Congenital Ichthyosis

By Happy Mohamed

June 20, 8:19 AM

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for Pediatric

TMBR

2 minute read

Lexicon To Present Study Results Relating To LX9211 And INPEFA At The American Diabetes Association’s 83rd Scientific Sessions

By Happy Mohamed

June 20, 8:17 AM

LX9211 is an investigational, non-opioid treatment for diabetic peripheral neuropathic pain INPEFA recently approved for treatment of heart failure THE WOODLANDS, Texas, June 20, 2023 (GLOBE NEWSWIRE)

LXRX

1 minute read

C3 AI Presenting Now At Wedbush Securities AI Event “AI Revolution: Diving Into the AI Theme”

By Benzinga Newsdesk

June 16, 11:05 AM

C3 AI (NYSE:AI), the Enterprise AI application software company, today announced that C3 AI CEO Thomas M. Siebel will be participating in Wedbush's "AI Revolution: Diving Into the AI Theme" virtual conference on June 16,

4 minute read

Sana Biotechnology Highlights Preclinical Data From Hypoimmune And Fusogen Platforms At The International Society For Stem Cell Research 2023 Annual Meeting

By Benzinga Newsdesk

June 16, 9:08 AM

Hypoimmune (HIP)-modified CD19-directed CAR T cells have the potential to serve as a universal off-the-shelf therapy that provides long-term durability of response without immunosuppression HIP-modified primary

SANA

4 minute read

Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data In An Oral Presentation At The International Conference On Malignant Lymphoma Lugano

By Benzinga Newsdesk

June 15, 9:30 AM

Presentation Includes Data on All 33 CAR T-Naïve Patients Treated with the Alloy™ Manufactured Material and Recaps Data on 12 Large B Cell Lymphoma Patients Treated with Phase 2 Dose RegimenResults Indicate an

ALLO

1 minute read

Next Generation Chemotherapy Improved Treatment For More Patients; Will Present At The Medinvest Oncology Investor Conference Being Held On June 21-22, 2023 In Boston, MA

By Benzinga Newsdesk

June 14, 4:17 PM

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and

PCSA

2 minute read

Tesla Stock Is Up More Than 50% Over The Past Month: Why Jim Cramer Is Calling It ‘The Princess Bride’ Rally

By Adam Eckert

June 14, 1:22 PM

Tesla Inc (NASDAQ: TSLA) shares have staged an impressive rally over the past month, setting a new record for most consecutive green days along the way.

TSLA